NEO-GAP: A Single-Arm, Phase II Feasibility Trial of Neoadjuvant Gemcitabine, Cisplatin, and Nab-Paclitaxel for Resectable, High-Risk Intrahepatic Cholangiocarcinoma
Shishir K. Maithel, Jessica M. Keilson, Hop S. Tran Cao, Manali Rupji, Amit Mahipal, Bruce Lin, Milind Javle, Sean P. Cleary, Mehmet Akce, Jeffrey M. Switchenko, Flavio G. Rocha
Topics & Concepts
MedicineGemcitabineInternal medicineIntrahepatic CholangiocarcinomaNeutropeniaClinical endpointAdverse effectSurgical oncologyOncologyResponse Evaluation Criteria in Solid TumorsNeoadjuvant therapyFebrile neutropeniaCisplatinSurgeryChemotherapyPhases of clinical researchCancerClinical trialBreast cancerCholangiocarcinoma and Gallbladder Cancer StudiesGallbladder and Bile Duct DisordersPancreatic and Hepatic Oncology Research